Gender-related differences in functional assessment of serotonergic system in healthy young subjects

Actas Espanolas de Psiquiatria

Volumn 36, Issue 4, 2008, Pages 218-222

  Silva, H ^a   Nieto, R ^a   Montes, C ^a   Paredes, A ^a   Renteria P ^a   Ramirez A ^a   Jerez S ^a  

^a UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Challenge; Estrogen; Gender; Prolactin; Serotonin; Stimulation

Indexed keywords

BIOLOGICAL MARKER; DIAGNOSTIC AGENT; ESTROGEN; FENFLURAMINE; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; FEMALE; HEALTH STATUS; HUMAN; MALE; METABOLISM; SEX DIFFERENCE; TIME;

ADULT; BIOLOGICAL MARKERS; ESTROGENS; FEMALE; FENFLURAMINE; HEALTH STATUS; HUMANS; MALE; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; TIME FACTORS;

EID: 49749088356     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sher L, Oquendo M, Li S, Ellis S, Brodsky BS, Malone KM, et al. Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls. Psychoneuroendocrinology 2003;28:559-73.
2. Soloff PH, Kelly TM, Strotmeyer SJ, Malone KM, Mann JJ. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res 2003;119:11-24.
3. Eckel LA, Rivera HM, Atchley DP. The anorectic effect of fenfluramine is influenced by sex and stage of the estrous eycle in rats. Am J Physlol Regul Integr Comp Physiol 2005;288:1486-91.
4. Coccaro E. Central serotonin and impulse aggression. Br J Psychiatry 1989;155(Suppl. 8):52-62.
5. Oquendo M. The biology of impulsivity and suicidality. Psychiatr Clin North Am 2000;23:11-25.
6. Coccaro E, Kavocessi R, Cooper T, Hauger R. Central serotonin activity and aggression: inverse relationship with prolactin response to D-fenfluramine but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry 1997;154:1430-5.
7. Invernizzi R, Berettera C, Garattini S, Samanin R. D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol 1986;120:9-15.
8. Garattini S, Mennini T, Samanin R. From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotonergic system and food intake. Ann N Y Acad Sci 1987;499:156-66.
9. McBride PA, Tierney H, Demeo M, Chen J, Mann J. Effects of age and gender on CNS serotonergic responsivity on normal adults. Biol Psychiatry 1990,27:1143-55.
10. Muldoon M, Manuck S, Jansma C, Moore A, Perel J, Mann JJ. D,L-Fenfluramine Challenge Test: experience in nonpatient sample. Biol Psychiatry 1996;39:761-8.
11. Ramasubbu R, Flint A, Brown G, Awad G, Kennedy S. Neurohormonal responses to d-fenfluramine in healthy elderly subjects. A placebo-eontrolled study. Psychoneuroendocrinology 2000; 25:139-50.
12. Ghaziuddin N, Welch K, Greden J. Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents. Neuropsychopharmaeology 2003;28:133-9.
13. O'Keane V, O'Hanlon M, Webb M, Dinant T. D-fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration. Clin Endocrinol 1991;34: 289-92.
14. Goldberg DP. The detection of psychiatric illness by questionnaire. Oxford: Oxford University Press, 1972.
15. Goldberg DP, Williams P. A user's guide to the General Health Questionnaire. Berkshire: Nfer-Nelson, 1991.
16. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J. Effect of aging in human cortical pre and postsynaptic serotonin binding sites. Brain Res 1993;620:163-6.
17. Van Amelsvoort TA, Abel KM, Robertson DM, Daly E, Critchley H, Whitehead M, et al. Prolactin response to D-fenfluramine in postmenopausal women on and off ERT: comparison with young women. Psychoneuroendocrinology 2001;26:493-502.
18. Yamamoto M, Suhara T, Okubo Y, Ichimita T, Sudo Y, Inoue M, et al. Age-related decline of serotonin transporters in human brain of healthy males. Life Sci 2002;71:751-2.
19. Weiss LA, Abney M, Cook EH Jr, Ober C. Sex-specific genetic architecture of whole blood serotonin levéis. Am J Hum Genet 2005;76:33-41.
20. Cadoret RJ, Langbehn D, Caspers K, Troughton EP, Yucuis R, Sandhu HK, et al. Associations of the serotonin transporter promoter polymorphism with aggressivity, attention deficit, and conduct disorder in an adoptee population. Compr Psychiatry 2003;44:88-101.
21. Lu H, Nishi M, Matsuda K, Kawata M. Estrogen reduces the neurite growth of serotonergic cells expressing estrogen receptors. Neurosci Res 2004;50:23-8.
22. Mitchell PB, Smythe GA. Endocrine and amine responses to D,L-fenfluramine in normal subjects. Psychiatry Res 1991;39: 141-53.
23. Cheymol G, Weissenburger J, Poirier JM, Gellee C. The pharmacokinetics of dexfenfluramine in obese and non-obese subjects. Br J Clin Pharmacology 1995;39:684-7.